Potential Health Policy Administrative Actions in the Second Trump Administration
Explore our guide to potential health policy administrative actions under the incoming Trump administration based on campaign positions and statements by President-elect Trump, his record during his first administration, and expected actions that would reverse or modify regulations or guidance issued by the Biden administration.
Medicare Spent 27% More for People who Disenrolled from Medicare Advantage
Latest News
-
Helicopters Rescued Patients in ‘Apocalyptic’ Flood. Other Hospitals Are at Risk, Too.
-
How Are States Spending Opioid Settlement Cash? We Built a Database of Answers
-
More Californians Are Freezing to Death. Experts Point to More Older Homeless People.
-
Removing a Splinter? Treating a Wart? If a Doctor Does It, It Can Be Billed as Surgery
-
News Influencers, Opioid Disparities, and AI Bias in Healthcare
The latest monitor examines the role of news influencers in spreading misinformation, misleading narratives amid disparities in opioid overdose rates, and biases in artificial intelligence (AI) in healthcare.
-
How HHS, FDA, and CDC Can Influence U.S. Vaccine Policy
While there are limits, federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the U.S.
-
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid
The Biden administration proposal would allow Medicare and require Medicaid to cover drugs used to treat obesity, expanding access while raising spending.
-
Beyond the Data, a Column by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.